New drugs to
transform anesthesia.

Better for patients,
and the planet.

Be part of it

The first development-stage inhaled general anesthetic in decades.
And that's just the beginning.

Expanesthetics is the global leader in the development of new inhaled general anesthetics. Our lead drug candidate is the first new inhaled agent to reach the development stage since the early nineties.

Aside from developing our drugs for clinical improvements, we're also developing them to be climate-friendly — thrown out with the surgical trash instead of being vented to the atmosphere. And we're working on applying the same technology to conventional anesthetics.

You're invited to join the brave pioneers powering this work (including over 100 anesthesia clinicians).

Explore the Company